Definition: triiodothyronine levels decrease in infants and children after cardiopulmonary bypass. Lower T3 concentration is associated with a more complicated recovery in PICU after congenital heart surgery. T3 is safe and has proven clinical benefit in infants less than 5 months of age. Given prophylactically before and after cardiopulmonary bypass, T3 decreases ventilation time and inotrope requirement and improves cardiac function compared to placebo.
Infants less than 5 months of age having congenital heart surgery with cardiopulmonary bypass.
T3 treatment regimen:
- 0.4 mcg/kg immediately prior to going on to CPB
- 0.4 mcg/kg on release of aortic cross clamp
- 0.2 mcg/kg at 3 hrs after cross clamp removal
- 0.2 mcg/kg at 6 hrs after cross clamp removal
- 0.2 mcg/kg at 9 hrs after cross clamp removal
A single vial can be used for multiple doses for a single patient up to 24 hrs after opening, but must be kept in the fridge once open.
References: Bartkowski, R., et al., Thyroid hormones levels in infants during and after cardiopulmonary bypass with ultrafiltration. Eur J Cardiothorac Surg, 2002. 22(6): p. 879-84.  Plumpton, K. et al, Identifying infants at risk of marked thyroid suppression post-cardiopulmonary bypass. Intensive Care Med, 2005. 31(4): p. 581-7.  Plumpton, K.R., B.J. Anderson, and J. Beca, Thyroid hormone and cortisol concentrations after congenital heart surgery in infants younger than 3 months of age. Intensive Care Med, 2009. 36(2): p. 321-8.  Portman, M.A., et al., Triiodothyronine Supplementation in Infants and Children Undergoing Cardiopulmonary Bypass (TRICC): a multicenter placebo-controlled randomized trial: age analysis. Circulation, 2010. 122(11 Suppl): p. S224-33.